缺血性与扩张型心肌病中功能性二尖瓣反流IIIb型的瓣下修复对比
本研究分析了84例重度功能性二尖瓣反流、左室射血分数<40%、左室舒张末径≥55 mm且瓣叶栓系高度>10 mm的心衰患者,均接受瓣环成形联合双侧乳头肌复位。前瞻性比较54例缺血性心肌病与30例扩张型心肌病患者1年结局,两组生存率和主要复合终点相似,扩张型心肌病组左室舒张末径显著缩小。
要点
- 标准化双侧乳头肌复位在缺血性与扩张型心肌病中均获满意院内及1年结局。
- 两组1年生存率相似(96% vs 97%,P=0.93)。
- 扩张型心肌病组左室舒张末径较术前显著缩小(P=0.018),缺血性组未达显著(P=0.058)。
核心结论
- 标准化双侧乳头肌复位矫正功能性二尖瓣反流在缺血性与扩张型心肌病中均获满意院内及1年结局。
- 扩张型心肌病患者心衰症状改善和左室逆重构与缺血性心肌病患者相似。
- 瓣下修复正发展成为重度功能性二尖瓣反流心衰患者的有效治疗选择。
研究设计与样本
- 分析84例连续心衰患者,重度功能性二尖瓣反流、左室射血分数<40%、左室舒张末径≥55 mm、瓣叶栓系高度>10 mm。
- 所有患者接受瓣环成形联合双侧乳头肌复位,手术时间2016年6月至2019年3月。
- 前瞻性比较54例缺血性心肌病组与30例扩张型心肌病组的1年结局。
主要发现
- 1年生存率两组相似:缺血性心肌病组96% vs 扩张型心肌病组97%,P=0.93。
- 1年主要复合终点(免于死亡或二尖瓣反流≥2)两组可比:缺血性心肌病组94% vs 扩张型心肌病组87%,P=0.10。
- 扩张型心肌病组术后1年左室舒张末径较术前显著缩小(P=0.018),缺血性心肌病组未达显著(P=0.058)。
- 两组1年纽约心功能分级改善和血清N末端B型利钠肽原水平降低程度可比。
关键数值与推荐
- 入选标准:重度功能性二尖瓣反流、左室射血分数<40%、左室舒张末径≥55 mm、瓣叶栓系高度>10 mm。
- 主要复合终点为免于死亡或二尖瓣反流≥2。
临床怎么用
- 对重度功能性二尖瓣反流伴左室扩大和瓣叶栓系的心衰患者,可考虑瓣环成形联合双侧乳头肌复位。
- 缺血性与扩张型心肌病患者均可从该瓣下修复策略中获益,1年结局相似。
- 扩张型心肌病患者术后左室逆重构可能更明显,但需注意缺血性组未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Functional mitral regurgitation (FMR) is a sequel of left ventricular (LV) remodelling in heart failure patients. Relocation of both papillary muscles aims to specifically address mitral leaflet tethering to improve long-term durability of modern FMR repair. Nevertheless, the prognostic impact of the underlying cardiomyopathy on the outcome after FMR repair is unknown. METHODS: We analysed 84 consecutive heart failure patients with severe FMR, LV ejection fraction <40%, LV end-diastolic diameter ≥55 mm and tenting height >10 mm, who underwent ring annuloplasty and simultaneous bilateral papillary muscles relocation between June 2016 and March 2019. One-year outcome of 54 patients with ischaemic cardiomyopathy ('ICM group') was prospectively compared to the remaining 30 patients with dilated cardiomyopathy ('DCM group'). RESULTS: One-year survival was similar in both groups (96% in the 'ICM group' vs 97% in the 'DCM group'; P = 0.93). Furthermore, primary composite outcome (i.e. freedom from death or mitral regurgitation ≥ 2) at 1-year postoperatively was comparable between the study groups (94%in the 'ICM group' vs 87% in the 'DCM group'; P = 0.10). LV end-diastolic diameter 1-year after surgery was significantly reduced, as compared to preoperative values, in the 'DCM group' (P = 0.018), but not in the 'ICM group' (P = 0.058). Improvement of New York Heart Association functional class and reduction of serum levels of N-terminal pro-B natriuretic peptide at 1 year was comparable in both study groups. CONCLUSIONS: Standardized relocation of both papillary muscles to correct FMR resulted in very satisfactory in-hospital and 1-year outcomes, in both ICM and DCM. DCM patients showed similar improvement in heart failure symptoms and LV re-remodelling compared to ICM patients. Subannular repair is developing towards a valid therapeutic option in heart failure patients presenting with severe FMR.
引用
- Pausch J, Sequeira Gross T, Müller L, et al. Subannular repair for functional mitral regurgitation type IIIb in patients with ischaemic versus dilated cardiomyopathy. Eur J Cardiothorac Surg. 2021. PMID: 33693797. doi:10.1093/ejcts/ezab048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。